Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Current Opinion in Immunology|October 14, 2025
Treating sarcoidosis: when less is moreNiamh Logan, Jessica Raja, Elisabetta A RenzoniInternational Journal of Rheumatology|September 19, 2012
Circulating biomarkers of interstitial lung disease in systemic sclerosisHarpreet K Lota, Elisabetta A RenzoniMolecular Diagnosis & Therapy|June 18, 2014
Molecular biomarkers in interstitial lung diseasesAngelo De Lauretis, Elisabetta A RenzoniAmerican Journal of Respiratory Cell and Molecular Biology|May 8, 2010
Endothelin in pulmonary fibrosisCarmen Fonseca, David Abraham, Elisabetta A RenzoniEuropean Journal of Human Genetics : EJHG|February 25, 2018
Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literatureCarmel J W Stock, Elisabetta A RenzoniJournal of Clinical Medicine|April 3, 2021
Telomeres in Interstitial Lung DiseaseCarmel J W Stock, Elisabetta A RenzoniLancet (London, England)|September 9, 2021
Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?Elisabetta A Renzoni, Venerino Poletti, John A MackintoshCurrent Opinion in Pulmonary Medicine|July 7, 2021
Sarcoidosis and maligancy: the chicken and the egg?Martina Bonifazi, Elisabetta A Renzoni, Elyse E LowerCurrent Pulmonology Reports|March 28, 2017
Idiopathic Pleuroparenchymal FibroelastosisMartina Bonifazi, M Angeles Montero, Elisabetta A RenzoniAnnals of Medicine|January 24, 2015
Pharmacologic therapies for idiopathic pulmonary fibrosis, past and futureBashar S Staitieh, Elisabetta A Renzoni, Srihari VeeraraghavanPageof 12